Moneycontrol
Get App
Last Updated : Feb 06, 2015 05:06 PM IST | Source: CNBC-TV18

Serum Institute in 'initial talks' to explore Cipla merger

After tying up with drugmaker Cipla to market its products last year, the Poonawalla Group's Serum Institute, the world's largest vaccine maker, is considering the option of merging with it.


After tying up with drugmaker Cipla to market its products last year, the Poonawalla Group's Serum Institute, the world's largest vaccine maker, is considering the option of merging with it.


In an exclusive chat with CNBC-TV18's Shereen Bhan, the institute's billionnaire founder, Cyrus Poonawalla, said that while Serum will not be put up for sale, a merger between the two companies could result in synergies for both.


"A little bit of talks [to discuss the merger] have happened. There is a small chance of it happening," he said, adding that the potential of such a development would also depend on how their tie-up in Europe proceeds.

Close

In November last year, Cipla had tied up with Serum to market the latters' vaccines in Europe, where, according to Poonawalla, it enjoys experience in marketing.

"We have to see how the initial partnership bears fruit. If it moves in the right direction, maybe we will take it to the next stage."



Subscribe to Moneycontrol Pro and gain access to curated markets data, exclusive trading recommendations, independent equity analysis, actionable investment ideas, nuanced takes on macro, corporate and policy actions, practical insights from market gurus and much more.
First Published on Feb 6, 2015 05:05 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant